FOXO proteins help to maintain quiescence in CML stem cells [51] and can promote apoptosis in CML cells treated with ABL tyrosine kinase inhibitors [52, 53]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.